dm+d
108943009
Articles
Specific medicine switches for solid dose and liquid formulations
13 September 2023
Certain medicines require additional monitoring and dose adjustments when switching between solid dose and liquid formulations. Safety considerations when using Vitamin D
7 September 2022
Healthcare professionals who use vitamin D should be aware of the risks of toxicity and safe practice principles which may prevent patient harmChoosing an oral vitamin D preparation for vegetarians or vegans
13 December 2021
An explanation as to why the source of vitamin D, or inactive ingredients (excipients) in products, may make preparations unsuitable for vegetarians or vegans.Choosing a calcium and vitamin D preparation for vegetarians or vegans
6 July 2021
This article explains how the source of vitamin D, or the inactive ingredients (excipients), may make preparations unsuitable for vegetarians or vegans. Vitamin D: Is there a licensed product suitable for a patient with peanut or soya allergy?
23 September 2020
This document contains a table giving information from the manufacturers regarding the peanut or soya content of their licensed vitamin D products at the time…Lactation Safety Information
Cholecalciferol, vitamin D3
Cholecalciferol, vitamin D3
Colecalciferol is formed by the interaction of cholesterol with UV light. It is further converted in the body to its active form, 1,25-dihydroxycholecalciferol (calcitriol)
Prevention of maternal vitamin D deficiency with doses of up to 400 units (10 micrograms) daily are considered safe with breastfeeding
Pharmacological doses (normally from 10,000 units daily) in the mother should be avoided if possible. If clinically necessary monitor infant’s calcium levels
3 August 2019